Otarmeni News

Sensorion pivots to SENS-601 after Regeneron’s OTOF hearing loss advance

FDA · hearing loss · 4 min

FDA Approves Otarmeni: First Gene Therapy for Genetic Hearing Loss Under Priority Voucher Program

FDA · Genetic Hearing Loss · 3 min

FDA Approves Regeneron's Otarmeni: First Gene Therapy for Genetic Hearing Loss Shows 80% Success Rate

FDA · Genetic Hearing Loss · 4 min